Brain SPECT Imaging with 99Tcm-hexamethylpropyleneamine Oxime in the Early Detection of Cerebral Infarction: Comparison with Transmission Computed Tomography

Overview

Journal Nucl Med Commun

Specialty Nuclear Medicine

Date 1986 Dec 1

PMID 3494968

Citations 6

Authors

S H Yeh

R S Liu

H H Hu

W J Wong

Y K Lo

Z Y Lai

J C Huang

S L Chang

S J Wang

F L Chu

Affiliations

Soon will be listed here.

Abstract

A new cerebral blood flow agent, 99Tcm-hexamethylpropyleneamine oxime (HM-PAO), was evaluated for early detection of acute cerebral infarction in conjunction with the transmission computed tomographic (CT) studies. The data from 22 cases were analysed. Results reveal that 99Tcm-HM-PAO enables the early detection of acute cerebral infarction prior to CT with rather proper depiction of the extent of physiological abnormality in the majority of patients. This promising result together with the lack of logistical problems will make 99Tcm-HM-PAO a useful and practical agent worldwide for diagnosing and managing acute cerebral infarction.

Citing Articles

The Legacy of the TTASAAN Report-Premature Conclusions and Forgotten Promises: A Review of Policy and Practice Part I.

Pavel D, Henderson T, DeBruin S Front Neurol. 2022; 12:749579.

PMID: 35450131 PMC: 9017602. DOI: 10.3389/fneur.2021.749579.

Advanced imaging modalities in the detection of cerebral vasospasm.

Mills J, Mehta V, Russin J, Amar A, Rajamohan A, Mack W Neurol Res Int. 2013; 2013:415960.

PMID: 23476766 PMC: 3580927. DOI: 10.1155/2013/415960.

Evaluation of cerebral vasospasm in patients with subarachnoid hemorrhage using single photon emission computed tomography.

Naderi S, Ozguven M, Bayhan H, Gokalp H, Erdogan A, Egemen N Neurosurg Rev. 1994; 17(4):261-5.

PMID: 7753413 DOI: 10.1007/BF00306813.

Quantitative assessment of cerebral blood flow using technetium-99m-hexamethyl-propyleneamine oxime: Part I, Design of a mathematical model.

Matsuda H, Oba H, Terada H, Tsuji S, Sumiya H, Shiba K Ann Nucl Med. 1988; 2(1):13-9.

PMID: 3275100 DOI: 10.1007/BF03164581.

The behavior of 99mTc-hexamethylpropyleneamineoxime (99mTc-HMPAO) in blood and brain.

Nakamura K, Tukatani Y, Kubo A, Hashimoto S, Terayama Y, Amano T Eur J Nucl Med. 1989; 15(2):100-7.

PMID: 2920737 DOI: 10.1007/BF00702628.